Background. Diabetes mellitus (DM) is frequently observed in patients with acromegaly. Current therapies for acromegaly may impact glucose regulation, influencing insulin sensitivity and secretion. The question whether these therapies modify control and progression of diabetes once present is still open. Aim. Aim of our study is to analyse glucose control in acromegalic patients with diabetes, evaluating the relation with treatments for GH excess and for diabetes. Methods. Seventy patients with acromegaly and diabetes were studied. Duration and treatments of acromegaly and DM were recorded, together with clinical and metabolic parameters. Results. Most patients (92.8%) were treated with somatostatin analogs (SSAs), either alone or in combination with dopamine-agonists (20%) or pegvisomant (15.7%). 7.1% patients had been treated by surgery alone. Metformin (65.7%), alone or in combination with other hypoglycaemic drugs, was the most frequent treatment for diabetes, followed by insulin (21.5%). Only 15.7% were treated with diet alone. The whole cohort showed a very good control of diabetes and acromegaly. Median glycated hemoglobin A1c (HbA1c) was 6.4% (5.9-7). IGF-1 was within normal range for age in most patients. No relation was observed between duration of acromegaly or diabetes and metabolic control. SSAs had a negative effect on insulin secretion, but these effects did not influence glucose control. Finally, we observed a low prevalence of nephropathy (6%) and retinopathy (20%). Conclusions. Our study shows that a good control of hyperglycemia can be obtained with success in the majority of acromegalic patients with diabetes, independently from the type of treatment for GH excess.

Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia / Cambuli, Vm; Galdiero, Mariano; Mastinu, M; Pigliaru, F; Auriemma, Rs; Ciresi, A; Pivonello, Rosario; Amato, M; Giordano, C; Mariotti, S; Colao, Annamaria; Baroni, M. G.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - STAMPA. - 35:2(2012), pp. 154-159. [10.3275/7685]

Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia.

Cambuli VM;GALDIERO, MARIANO;PIVONELLO, ROSARIO;COLAO, ANNAMARIA;
2012

Abstract

Background. Diabetes mellitus (DM) is frequently observed in patients with acromegaly. Current therapies for acromegaly may impact glucose regulation, influencing insulin sensitivity and secretion. The question whether these therapies modify control and progression of diabetes once present is still open. Aim. Aim of our study is to analyse glucose control in acromegalic patients with diabetes, evaluating the relation with treatments for GH excess and for diabetes. Methods. Seventy patients with acromegaly and diabetes were studied. Duration and treatments of acromegaly and DM were recorded, together with clinical and metabolic parameters. Results. Most patients (92.8%) were treated with somatostatin analogs (SSAs), either alone or in combination with dopamine-agonists (20%) or pegvisomant (15.7%). 7.1% patients had been treated by surgery alone. Metformin (65.7%), alone or in combination with other hypoglycaemic drugs, was the most frequent treatment for diabetes, followed by insulin (21.5%). Only 15.7% were treated with diet alone. The whole cohort showed a very good control of diabetes and acromegaly. Median glycated hemoglobin A1c (HbA1c) was 6.4% (5.9-7). IGF-1 was within normal range for age in most patients. No relation was observed between duration of acromegaly or diabetes and metabolic control. SSAs had a negative effect on insulin secretion, but these effects did not influence glucose control. Finally, we observed a low prevalence of nephropathy (6%) and retinopathy (20%). Conclusions. Our study shows that a good control of hyperglycemia can be obtained with success in the majority of acromegalic patients with diabetes, independently from the type of treatment for GH excess.
2012
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia / Cambuli, Vm; Galdiero, Mariano; Mastinu, M; Pigliaru, F; Auriemma, Rs; Ciresi, A; Pivonello, Rosario; Amato, M; Giordano, C; Mariotti, S; Colao, Annamaria; Baroni, M. G.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - STAMPA. - 35:2(2012), pp. 154-159. [10.3275/7685]
File in questo prodotto:
File Dimensione Formato  
Cambuli 2012.pdf

solo utenti autorizzati

Tipologia: Altro materiale allegato
Licenza: Dominio pubblico
Dimensione 117.78 kB
Formato Adobe PDF
117.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/418504
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? ND
social impact